Brokerages expect Quintiles Transitional Holdings Inc. (NYSE:Q) to announce sales of $2.02 billion for the current quarter, according to Zacks Investment Research. Nine analysts have made estimates for Quintiles Transitional Holdings’ earnings, with the lowest sales estimate coming in at $2.00 billion and the highest estimate coming in at $2.03 billion. Quintiles Transitional Holdings posted sales of $1.14 billion in the same quarter last year, which would indicate a positive year over year growth rate of 77.2%. The company is scheduled to issue its next quarterly earnings results on Wednesday, November 1st.
According to Zacks, analysts expect that Quintiles Transitional Holdings will report full-year sales of $2.02 billion for the current fiscal year, with estimates ranging from $8.00 billion to $8.09 billion. For the next financial year, analysts forecast that the business will report sales of $8.52 billion per share, with estimates ranging from $8.44 billion to $8.61 billion. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow Quintiles Transitional Holdings.
Quintiles Transitional Holdings (NYSE:Q) last released its earnings results on Thursday, August 3rd. The medical research company reported $1.09 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.04. The company had revenue of $1.97 billion during the quarter, compared to the consensus estimate of $1.96 billion. Quintiles Transitional Holdings had a net margin of 0.82% and a return on equity of 14.23%. The company’s revenue was up 68.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.93 EPS.
Q has been the topic of a number of research analyst reports. Royal Bank Of Canada initiated coverage on Quintiles Transitional Holdings in a report on Tuesday, September 19th. They set an “outperform” rating and a $116.00 price target on the stock. KeyCorp restated a “buy” rating and set a $100.00 price target on shares of Quintiles Transitional Holdings in a report on Sunday, September 24th. Argus increased their price target on Quintiles Transitional Holdings from $98.00 to $104.00 and gave the stock a “buy” rating in a report on Monday, September 18th. Zacks Investment Research upgraded Quintiles Transitional Holdings from a “hold” rating to a “buy” rating and set a $101.00 price target on the stock in a report on Thursday, July 27th. Finally, BidaskClub upgraded Quintiles Transitional Holdings from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 19th. Eleven analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Buy” and an average price target of $93.00.
Quintiles Transitional Holdings (NYSE:Q) traded up 0.10% during midday trading on Thursday, hitting $95.70. 1,546,728 shares of the stock traded hands. The company has a 50-day moving average of $95.40 and a 200-day moving average of $88.16. The stock has a market cap of $20.72 billion, a PE ratio of 277.39 and a beta of 0.62. Quintiles Transitional Holdings has a 1-year low of $70.10 and a 1-year high of $99.95.
In related news, insider Kevin C. Knightly sold 20,000 shares of the stock in a transaction on Wednesday, August 9th. The stock was sold at an average price of $90.28, for a total value of $1,805,600.00. Following the completion of the sale, the insider now directly owns 46,826 shares of the company’s stock, valued at approximately $4,227,451.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Kevin C. Knightly sold 19,339 shares of the stock in a transaction on Friday, August 25th. The shares were sold at an average price of $99.51, for a total value of $1,924,423.89. Following the completion of the sale, the insider now directly owns 40,650 shares of the company’s stock, valued at $4,045,081.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 14,198,382 shares of company stock worth $1,361,834,375. 6.40% of the stock is owned by company insiders.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in Q. BlackRock Inc. raised its position in Quintiles Transitional Holdings by 4,217.1% in the 1st quarter. BlackRock Inc. now owns 7,098,723 shares of the medical research company’s stock valued at $571,660,000 after buying an additional 6,934,290 shares during the last quarter. Janus Henderson Group PLC raised its position in Quintiles Transitional Holdings by 33,092.0% in the 2nd quarter. Janus Henderson Group PLC now owns 6,531,857 shares of the medical research company’s stock valued at $584,601,000 after buying an additional 6,512,178 shares during the last quarter. Glenview Capital Management LLC raised its position in Quintiles Transitional Holdings by 29.3% in the 2nd quarter. Glenview Capital Management LLC now owns 8,921,356 shares of the medical research company’s stock valued at $798,461,000 after buying an additional 2,023,719 shares during the last quarter. Royal Bank of Canada raised its position in Quintiles Transitional Holdings by 103.8% in the 2nd quarter. Royal Bank of Canada now owns 59,335 shares of the medical research company’s stock valued at $5,310,000 after buying an additional 1,601,888 shares during the last quarter. Finally, Discovery Capital Management LLC CT purchased a new stake in Quintiles Transitional Holdings in the 2nd quarter valued at $95,228,000. 93.21% of the stock is owned by institutional investors and hedge funds.
About Quintiles Transitional Holdings
Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with our FREE daily email newsletter.